Pdt Partners, LLC Shattuck Labs, Inc. Transaction History

Pdt Partners, LLC

  • $1.02 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.7 - $4.59 $37,154 - $63,162
-13,761 Reduced 30.94%
30,721 $125,000
Q1 2022

May 16, 2022
SELL
$4.22 - $8.89 $17,285 - $36,413
-4,096 Reduced 8.43%
44,482 $189,000
Q4 2021

Feb 14, 2022
BUY
$8.36 - $21.08 $406,112 - $1.02 Million
48,578 New
48,578 $413,000

Others Institutions Holding STTK

# of Institutions
80
Shares Held
28.8M
Call Options Held
300
Put Options Held
1.2K
View Full List

About Shattuck Labs, Inc.

STTK Quotes by TradingView
  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $55.1M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email